Call for Sponsors & Exhibitors
RNAi2013 encourages demonstration of R&D and laboratory supplies related to drug design and invites commercial sponsorship. You are invited to choose from a variety of highly-competitive sponsorship packages listed below. If your needs are not covered by the offered packages please contact us in the first instance and we shall do our best to develop a package to suit your requirements.
- Gold: Includes a speaker slot AND an exhibition stand (max 2)
- Silver: Includes a speaker slot OR an exhibition stand (max 2)
- Keynote Speakers
- Podium Sessions
- Refreshment Breaks
- Drinks Reception
- Delegate Bags (max 2)
- Delegate Badges (max 2)
- Conference Proceedings (max 2)
To increase interaction with delegates, refreshments will be held in the main exhibition area. Spaces for exhibitions are limited and will be allocated on a first-come-first-served basis. To get a location of choice, and to avail our special promotional offers we strongly recommend an early booking.
Exhibition package includes the following benefits:
- Admittance for TWO exhibitors (includes lunches and refreshments)
- Approximately 7 (w) x 4 (d) feet exhibition area (with 5 x 2 feet table top and two chairs)
- Invitation to submit a poster abstract
- On site parking for one car
- Free weblink to one preferred website and brief company description on the conference website and handbook
- Access to multiple use delegate email list
For a Booking Form and further information about packages and other promotional opportunities email on:
Terms & Conditions of Booking.
Sponsors and Exhibitor
Gold Sponsor and Exhibitor
Sigma-Aldrich is a global supplier of leading RNA interference (RNAi) tools including siRNA and the comprehensive MISSION™ shRNA library through participation in The RNAi Consortium (TRC). As a key licensed supplier of siRNA and expert in high quality custom DNA and RNA oligonucleotide synthesis, our goal is to provide innovative products to meet your functional genomics and gene silencing research needs. The MISSION shRNA library of The RNAi Consortium, developed by the Broad Institute of MIT and Harvard, is a pre-cloned collection targeted against annotated human and mouse genes enabling scientists to elucidate gene function. For further details of the above products please visit www.sigma-aldrich.com/rnai.
Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 35 countries and has over 6,800 employees providing excellent service worldwide. We are committed to accelerating Customers’ success through leadership in Life Science, High Technology and Service.
Silver Sponsor and Exhibitor
Eupheria Biotech GmbH: Our mission is dedication to our customer's research needs delivering high quality RNAi products combined with aligned services. We develop and produce RNAi reagents using cutting-edge technology, such as endoribonuclease prepared siRNAs (esiRNAs). Our company is continously aiming for innovations to provide the most efficient silencing triggers available in the market with substantially less off-target effects guaranteeing best results for our customers.
Our RNAi products provide RNAi researchers with a proven, cost effective and simple way to perform experiments, from single gene knockdown to genom-wide screens. Our enzymatically prepared, multiple silencing triggers lead to highly specific and effective gene silencing. We have just launched a brand new library of esiRNAs targeting long non-coding transcripts from the Mus Musculus genome in addition to the first commercially available library of RNAi mediators for Tribolium Castaneum.
Cellecta provides contract research services for the discovery and characterization of novel drug targets and the development of novel therapeutics. Cellecta’s genome-wide and targeted RNAi screening platform, which combines complex lentiviral shRNA expression libraries with HT sequencing, enables identification of genes regulating a variety of cellular responses and possible therapeutic targets and helps researchers identify new targets, prioritize known targets, characterize therapeutic mechanisms of action, and identify genes that induce an additive or synergistic response. The approach is particularly useful in elucidating the mechanism of action for compounds or other factors triggering cellular responses and for investigators interested in identifying essential genes in cancer models, finding cell signaling nodes modulating a functional response, or looking for genes that confer pathogenic resistance.
Cellecta is headed by an experienced management and product development team with a good product development track record, a network of outside scientific collaborators, and prior experience in start-up company operations. Located in Mountain View, CA in the heart of Silicon Valley, the company resides in the "Biotech Bay" area near some of the most well-known research biotech companies and life science institutes including Genentech, Stanford University, and the University of California, San Francisco.
Cellecta has partnered with a multitude of scientists and institutions, including the Roswell Park Cancer Institute, Fred Hutchinson Cancer Research Center (FHCRC), The Scripps Research Institute (TSRI), Cleveland Biolabs, Harvard School of Public Health, Tufts University, and Health Research, Inc. Cellecta’s scientists have developed some of the most advanced technologies available, in collaboration with opinion leaders and with funding from more than 12 NIH SBIR grants.
Delegate Badge Sponsor
Cenix BioScience GmbH is a contract research organization specialized in combining advanced applications of RNAi screening with high-content phenotypic analyses. Cenix has built up a dominant track record in this field, successfully advancing therapeutic programs for numerous industry and academic partners by providing fully customized, cutting-edge research offerings covering a wide range of disease fields including oncology, cardiovascular, metabolic, neurological and infectious diseases. The well-established core capabilities in high-throughput siRNA screening and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by miRNA screening, and in vivo RNAi applications using synthetic siRNAs. As such, Cenix is a mature and fully proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of specialist expertise second to none worldwide.
Exiqon - microRNA products and services: Exiqon offers microRNA products and services based on our proprietary LNA™ technology. Unlike DNA or RNA oligos, LNA™-enhanced primers and probes can be used to reliably detect short target sequences, making them ideal for microRNA research.
Exiqon’s miRCURY LNA™ product line covers the entire microRNA research process, from RNA isolation to functional analysis:
- miRCURY™ RNA Isolation Kit – Fast and easy total RNA extraction from a wide range of sample sources.
- miRCURY LNA™ microRNA Arrays – Highly sensitive and specific microRNA microarray expression profiling. LNA™-enhanced capture probes for detection of ALL microRNAs, including AU-rich sequences. Use our Hi-Power labeling kits for DOUBLE signal intensities.
- miRCURY LNA™ Universal RT microRNA PCR – Extremely sensitive and specific LNA™-enhanced qPCR system. Available in 96- and 384-well format and as pre-designed or custom-made individual assays. Profile 750 microRNAs using 40 ng total RNA in just 3 hours. Use Exiqon’s SYBR® Green master mix and cDNA synthesis kits for optimal performance.
- miRCURY LNA™ microRNA Detection Probes – Pre-designed LNA™-enhanced probes for in situ hybridization and Northern blot analysis. Available with a wide range of modifications and labels. Buffer and optimization kit also available.
- miRCURY LNA™ microRNA Inhibitors – Highly potent LNA™-enhanced microRNA inhibitors available for in vitro and in vivo silencing of microRNAs. Inhibitor libraries in 96-well format also available.
Exiqon also offers microRNA services. Let us prepare your RNA and perform your PCR or microarray microRNA experiments. We offer everything from an initial consultation to the final data analysis.
Learn more at www.exiqon.com
Carl Zeiss Microscopy is one of the leading manufacturers of microscope systems and offers complete solutions for biomedical research, the healthcare sector and high-tech industries. Its product line spans a broad spectrum from routine light microscopes to research level imaging systems and ultra-resolution systems.
Of special relevance is the MicroBeam system for laser capture microdissection (LCM). Enabling microdissection from tissue sections and live cell cultures without interfering with molecular integrity has provided powerful research breakthroughs. Single cells, or group of cells, can be micro-dissected away from the slide or dish using a cool ablative laser. Dissected elements are collected in a PCR tube for the downstream analysis of your choice (e.g. RNA analysis).
Molecular Devices: Gold Sponsor and Exhibitor
Sigma-Aldrich: Gold Sponsor and Exhibitor
Cenix BioScience GmbH: Delegate Badge Sponsor
Eupheria Biotech GmbH: Exhibitor
Integrated DNA Technologies (IDT): Exhibitor
Exiqon - microRNA products and services: Exhibitor
Journal of RNAi and Gene Silencing: Sponsoring Publication